Stocks
Bio-Rad Laboratories (BIO) EBITDA margin US GAAP (year values) |
||||||||
| 2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | 192.6% | -84.8% | -160.2% | -22.8% | 5.35% | ||
| Changes by years, y/y, % | -201pp | -277pp | -75pp | +137pp | ||||
Bio-Rad Laboratories. EBITDA margin, %
Bio-Rad Laboratories. EBITDA margin, changes, pp
Bio-Rad Laboratories (BIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | 72.5% | 90.2% | -427.2% | 213.9% | 142.0% | 5.35% | |
| Changes by years, y/y, % | +50pp | +68pp | -448pp | +183pp | +111pp | |||
| Changes by quarters, q/q, % | +41pp | +18pp | -517pp | +641pp | -72pp | |||
